|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation expense | |||||
| Stock-based compensation expense | |||||
| Changes in assets and liabilities: | |||||
| Government contract receivable | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Total adjustments | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Repayment of notes payable – related parties | |||||
| Net proceeds from sale of common stock and warrants | |||||
| Net proceeds from warrant exercises | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...